New potential therapeutic strategy against a very aggressive infant bone cancer

Researchers at the Bellvitge Biomedical Research Institute, led by Oscar Martínez Tirado participated in an international study which suggests inhibition of Sirtuin1 protein as a future treatment option for metastatic Ewing sarcoma. The results of the study were published in the journal Cancer Research. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *